Maureen Ortlieb

Maureen Ortlieb has a strong background in healthcare and pharmaceuticals, with extensive experience in strategic accounts and corporate account management.

Maureen is currently working as the Director of Strategic Accounts at Intercept Pharmaceuticals since July 2023.

From 2019 to April 2023, Maureen served as the Senior Corporate Account Director at Pear Therapeutics, where they led the company in prescription digital therapeutics and received FDA authorization for treating Substance Abuse Disorder and Opioid Abuse Disorder.

Prior to that, they worked at EMD Serono, Inc., starting as a National Account Manager in January 2010 and later transitioning to the role of Director of Corporate Accounts from April 2018 to September 2019.

Maureen also had a successful tenure at Schering-Plough, where they held various roles such as National Account Manager and National Customer Market Manager. Maureen demonstrated exceptional performance and achieved outstanding results throughout their time at the company.

Before joining Schering-Plough, they gained experience in healthcare research and marketing as the Coordinator of Bone Marrow Transplant Research and Marketing at Georgetown University Medical Center and as a Clinical Nurse at Memorial Sloan-Kettering Cancer Center.

Overall, Maureen Ortlieb possesses a wealth of experience and expertise in strategic accounts, corporate account management, prescription digital therapeutics, and healthcare research.

Maureen Ortlieb began their education at Georgetown Visitation Preparatory School from 1976 to 1980, where they completed their high school education. Maureen then attended Skidmore College from 1980 to 1984, earning a Bachelor of Science in Nursing Science. Following this, they pursued further education at Georgetown University from 1987 to 1988, where they obtained a Master of Science in Nursing and Business Administration.